Is the success of BCG tumour immunotherapy due to the induction of co-stimulatory molecules?
Alexandroff
A B
AB
Dept. Surgery, Edinburgh University Medical School, UK.
Mitchell
I
I
Black
J
J
James
K
K
D000283:Administration, Intravesical; D015703:Antigens, CD / Q000096:biosynthesis; D018122:B7-1 Antigen / Q000096:biosynthesis*; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000494:pharmacology; D019013:CD40 Antigens / Q000096:biosynthesis*; D002295:Carcinoma, Transitional Cell / Q000276:immunology / Q000628:therapy*; D002460:Cell Line; D006801:Humans; D007167:Immunotherapy; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis*; D015398:Signal Transduction; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000628:therapy*
D015703:Antigens, CD; D018122:B7-1 Antigen; D001500:BCG Vaccine; D019013:CD40 Antigens; D018799:Intercellular Adhesion Molecule-1